A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

Clinical trial NCT07285291 · RECRUITING

Trial details

NCT number: NCT07285291
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphosphatemia Patients on Hemodialysis

Start date: 2026-01-09
Primary completion: 2026-12-22
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.